PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 139 filers reported holding PLIANT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,438,237 | -4.3% | 2,678,099 | 0.0% | 2.21% | +18.6% |
| Q2 2023 | $48,527,154 | -37.6% | 2,678,099 | -8.5% | 1.86% | -44.8% |
| Q1 2023 | $77,822,237 | +3.8% | 2,925,648 | -24.6% | 3.38% | +10.1% |
| Q4 2022 | $74,973,319 | -20.4% | 3,878,599 | -14.0% | 3.07% | -16.0% |
| Q3 2022 | $94,176,000 | +283.1% | 4,508,204 | +46.9% | 3.65% | +289.0% |
| Q2 2022 | $24,583,000 | +13.8% | 3,069,001 | -0.4% | 0.94% | +39.3% |
| Q1 2022 | $21,596,000 | -48.1% | 3,080,801 | -0.1% | 0.67% | -28.8% |
| Q4 2021 | $41,627,000 | -20.0% | 3,083,501 | 0.0% | 0.95% | +4.2% |
| Q3 2021 | $52,049,000 | -43.4% | 3,083,501 | -2.3% | 0.91% | -33.2% |
| Q2 2021 | $91,914,000 | -27.1% | 3,156,401 | -1.6% | 1.36% | -23.5% |
| Q1 2021 | $126,139,000 | +63.9% | 3,207,193 | -5.3% | 1.78% | +90.7% |
| Q4 2020 | $76,984,000 | +0.2% | 3,388,376 | -0.1% | 0.93% | -33.9% |
| Q3 2020 | $76,823,000 | -30.6% | 3,391,757 | -0.6% | 1.41% | -31.0% |
| Q2 2020 | $110,710,000 | – | 3,410,657 | – | 2.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 339,160 | $5,881,034 | 100.00% |
| CHI Advisors LLC | 3,014,199 | $52,266,211 | 20.72% |
| TRV GP IV, LLC | 2,132,867 | $36,983,914 | 13.93% |
| GREAT POINT PARTNERS LLC | 1,755,184 | $30,434,891 | 5.54% |
| First Light Asset Management, LLC | 2,933,260 | $50,862,728 | 4.83% |
| Deep Track Capital, LP | 5,500,000 | $95,370,000 | 3.68% |
| Casdin Capital, LLC | 1,577,108 | $27,347,053 | 3.03% |
| Fernwood Investment Management, LLC | 379,702 | $6,584,033 | 2.37% |
| Redmile Group, LLC | 2,678,099 | $46,438,237 | 2.21% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 250,409 | $4,342,092 | 1.32% |